BioAtla Stock (NASDAQ: BCAB) stock price, news, charts, stock research, profile.
You can purchase shares of BioAtla (NASDAQ:BCAB) through any online brokerage.
Other companies in BioAtla’s space includes: CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Cellectar Biosciences (NASDAQ:CLRB), Immuneering (NASDAQ:IMRX) and Aligos Therapeutics (NASDAQ:ALGS).
BioAtla has a consensus price target of $14.17.
The stock price for BioAtla (NASDAQ: BCAB) is $1.64 last updated November 22, 2024 at 7:45 PM EST.
There are no upcoming dividends for BioAtla.
BioAtla’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for BioAtla.
BioAtla is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.